Stay updated on Lorlatinib Combos in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.

Latest updates to the Lorlatinib Combos in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry, v3.6.6, was added to the study record history, indicating the page was updated to the latest release version. This reflects a maintenance update to the record rather than changes to trial content or eligibility.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe revision label in the study history updates from v3.6.4 to v3.6.5. This reflects a newer version of the page metadata rather than any study data change.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now lists Revision: v3.6.4, replacing v3.6.3, representing an updated release notes/version for the study record. This reflects the latest update to the study's documentation in the history log.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry labeled v3.6.3 was added to the study record history, representing an updated version of the record. The underlying study details appear unchanged in this update, reflecting only the history log.SummaryDifference0.1%

- Check81 days agoChange DetectedThe record history now shows a new revision entry labeled v3.6.2, replacing the older v3.6.0 in the revision list. This reflects an update to the page's revision metadata rather than changes to the study data.SummaryDifference0.1%

- Check95 days agoChange DetectedThe study record history now reflects the latest revision (v3.6.0) with Ibiayi Dagogo-Jack, M.D. as the responsible party and a Last verified timestamp; the previous verbiage including 'Last known status was: Verified' and author details was removed.SummaryDifference3%

Stay in the know with updates to Lorlatinib Combos in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorlatinib Combos in Lung Cancer Clinical Trial page.